SOURCE: Antisoma plc

February 07, 2007 07:00 ET

Antisoma to present at the BIO CEO conference

LONDON, UK -- (MARKET WIRE) -- February 7, 2007 --



7 February 2007, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Director of Communications, Dr Daniel Elger, will be presenting at the BIO CEO and Investor Conference in New York on Monday 12 February. Dr Elger's presentation will take place at 2.45pm EST.

A live webcast of the presentation can be viewed on Antisoma's website and will be available thereafter at www.antisoma.com. For the live webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Dr Elger will also participate in a panel session entitled "Ovarian Cancer - Treatments Obviously Needed for a Not-So-Obvious Disease" on Monday 12 February at 3.30pm EST. Antisoma's presentation will consider the potential to improve outcomes in patients with ovarian cancer, focusing on combination therapy with the Company's vascular disrupting agent, AS1404.

Enquiries:
Katherine Harrison/Chris Elston
Communications Manager                    +44 (0)20 8799 8200


Background on Antisoma

Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information about Antisoma.






Copyright © Hugin ASA 2007. All rights reserved.

Contact Information